Arney 100mg Tablet

About

Arney 100mg Tablet is a combination medication containing sacubitril and valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI). It is indicated for the treatment of chronic heart failure with reduced ejection fraction in adult patients. Sacubitril inhibits neprilysin, an enzyme that degrades natriuretic peptides, leading to increased levels of these beneficial peptides. Valsartan is an angiotensin II receptor blocker (ARB) that inhibits the harmful effects of the renin-angiotensin-aldosterone system. This dual action helps to reduce cardiovascular stress, improve cardiac function, and significantly lower the risk of heart failure-related hospitalizations and mortality. It represents a significant advancement in the management of heart failure, offering a comprehensive approach to improve patient outcomes and quality of life by addressing multiple pathophysiological pathways involved in the disease progression.

Uses

• Chronic heart failure with reduced ejection fraction.
• To reduce the risk of cardiovascular death.
• To reduce the risk of heart failure hospitalization.
• Management of symptomatic chronic heart failure.

Directions For Use

Take orally as directed by your physician, usually twice daily. Swallow the tablet whole with water.

Benefits

• Reduces mortality in heart failure patients.
• Decreases hospitalizations for heart failure.
• Improves symptoms of heart failure.
• Enhances quality of life for patients.
• Offers a novel mechanism of action.
• Provides dual neurohormonal modulation.

Side Effects

• Hypotension (low blood pressure)
• Hyperkalemia (high potassium levels)
• Renal impairment (kidney problems)
• Angioedema (swelling under the skin)
• Dizziness or lightheadedness
• Cough
• Fatigue
• Nausea
• Diarrhea
• Back pain
• Anemia
• Syncope (fainting)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can exacerbate dizziness and hypotension.
• Pregnancy - Contraindicated in pregnancy due to potential fetal harm, including renal dysfunction and death.
• Breastfeeding - Not recommended during breastfeeding; consult a doctor for alternatives or to weigh risks.
• Liver - Use with caution in patients with mild to moderate hepatic impairment; not recommended in severe impairment.
• Kidney - Requires dose adjustment in moderate to severe renal impairment; monitor kidney function closely.
• Lung - Generally safe for use in patients with lung conditions, but monitor for cough.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.